Latest developments in Multiple Myeloma

We are excited to be hosting the Global Leader & Chief Medical Officer at the International Myeloma Foundation-- Dr. Joseph Mikhaelc where he discusses the latest developments and updates in Multiple Myeloma
Dr. Mikhael’s Career highlights:
-Global Authority on Multiple Myeloma, Cancer research, Drug discovery and translational genomics.
- Internationally-renowned clinical specialist in plasma cell disorders, including Multiple Myeloma, Amyloidosis & Waldenstrom’s Macroglobulinemia.
- Co-Program Director and Principal Investigator of the Phase I/II trial MLN9708 + Pomalidomide and Dexamethasone for Relapsed or Relapsed Refractory Multiple Myeloma.
- Leader of the FIRST EVER ASCO Guidelines for Multiple Myeloma.
- Recognized amongst the Top 100 Doctors in the United States (2018)
- Honored by his patients with Vital’s Compassionate Doctor Award (2014) & Vital’s Patient’s Choice Award (2008, 2014)
- Recipient of numerous awards, including Top Faculty Member (2014 & 2016) & Outstanding Faculty Member (2011) in Mayo Clinic, and the William Campbell Felch Award for Outstanding Research (2021)